Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. DeLauro investigates recent device approvals

This article was originally published in The Gray Sheet

Executive Summary

Rep. Rosa DeLauro, D-Conn., requests information from FDA on all devices, drugs and biologic products approved or cleared during the final days of the Bush administration - between November 2008 and January 2009. "I long have been concerned about the influence of industry and political interests in the approval process," DeLauro wrote in a Feb. 12 letter to acting FDA Commissioner Frank Torti. "I fear that this influence has permeated the culture of the agency and has resulted in the approval of a number of products that later were proven to be unsafe and/or ineffective." DeLauro asks for a response by Feb. 26
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT027115

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel